Abstract:miR-122 is a highly abundant, hepatocyte-specific microRNA. The biomedical significance and regulatory mechanisms of miR-122 remain obscure. We explored the role of miR-122 in tumorigenesis in the context of gene regulatory network. The miR-122 promoter and its transactivator were identified by way of luciferase reporter system, electrophoretic mobility shift, and chromatin immunoprecipitation assays. The miR-122 regulatory circuitry and its implication in hepatocarcinogenesis were identified using livers of different development stages, human hepatocellular carcinoma (HCC) tissues and cell lines, and aflatoxin B-1 (AFB(1))-transformed cells. We characterized the -5.3 to -4.8 kb region upstream of miR-122 precursor as miR-122 promoter. Further investigation revealed that deletion of predicted CCAAT/enhancer-binding protein alpha (C/EBP alpha) binding sites C/EBP alpha knockdown significantly reduced miR-122 promoter activity and endogenous miR-122 expression; and C/EBP alpha directly interacted with the miR-122 promoter in vitro and in vivo. These data suggest that C/EBP alpha is a transactivator for miR-122 transcription. We further demonstrated that miR-122 suppressed insulin-like growth factor 1 receptor (IGF-1R) translation and sustained glycogen synthase kinase-3 beta (GSK-3 beta) activity. The activated GSK-3 beta not only repressed cell proliferation, but also activated C/EBP alpha which maintained miR-122 levels and thereby enforced IGF-1R suppression. Interestingly, down-regulation of miR-122 and C/EBP alpha, and up-regulation of IGF-1R were frequently observed in HCC tissues, and decreased miR-122 levels were associated with worse survival of HCC patients. Moreover, AFB(1) exposure resulted in decreased activity in GSK-3 beta, C/EBP alpha and miR-122 and increased levels of IGF-1R, whereas restoration of miR-122 suppressed the tumorigenicity of HCC and AFB(1)-transformed cells. Conclusion: We have identified a novel GSK-3 beta-C/EBP alpha miR-122 IGF-1R regulatory circuitry whose dysfunction may contribute to the development of HCC. Our findings provide new insight into miR-122's function and the mechanisms of hepatocarcinogenesis. (HEPATOLOGY 2010;52:1702-1712)

A novel GSK-3β-C/EBPα-miR-122-IGF-1R regulatory circuitry in human hepatocellular carcinoma

MicroRNA‐122 Suppresses Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma by Directly Targeting Wnt/β‐catenin Pathway

MiR-144-3p-mediated Dysregulation of EIF4G2 Contributes to the Development of Hepatocellular Carcinoma Through the ERK Pathway

Decreased Expression of Hepatocyte Nuclear Factor 4α (Hnf4α)/microrna-122 (Mir-122) Axis in Hepatitis B Virus-associated Hepatocellular Carcinoma Enhances Potential Oncogenic GALNT10 Protein Activity

Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122

Epigenetically modulated miR-1224 suppresses the proliferation of HCC through CREB-mediated activation of YAP signaling pathway

MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties

Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2

Opposing Roles of C/EBPα and Eef1a1 in Sp1-regulated Mir-122 Transcription

Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma

Deregulation of Mir-520D-3p Promotes Hepatocellular Carcinoma Development Via Lncrna MIAT Regulation and EPHA2 Signaling Activation.

Liver-enriched Transcription Factors Regulate Microrna-122 That Targets CUTL1 During Liver Development.

Mir-1204 Promotes Hepatocellular Carcinoma Progression Through Activating MAPK and C-Jun/ap1 Signaling by Targeting ZNF418

Microrna-122 Affects Cell Aggressiveness and Apoptosis by Targeting Pkm2 in Human Hepatocellular Carcinoma

Over-expression of MiR-122 Promotes Apoptosis of Hepatocellular Carcinoma Via Targeting TLR4

Microrna-134 Inhibits Hcc Cell Growth And Migration Through The Akt/Gsk3 Beta/Snail Signaling Pathway

microRNA-122 inhibits hepatic stellate cell proliferation and activation in vitro and represses carbon tetrachloride-induced liver cirrhosis in mice

TGF-β1-Induced LINC01094 promotes epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-122-5p/TGFBR2–SAMD2–SMAD3 Axis

MicroRNA‑122 regulation of the morphology and cytoarchitecture of hepatoma carcinoma cells.

Abstract 3352: Mir-122 Targets Pyruvate Kinase M2 and Affects Metabolism of Hepatocellular Carcinoma

Mir-122 Targets Pyruvate Kinase M2 and Affects Metabolism of Hepatocellular Carcinoma